arrow
H

Hans-Gustaf Ljunggren

department of medicine huddinge
H指数:90
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
2024-11-010
PRE
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19

严重新型冠状病毒肺炎中I型干扰素自身抗体与细胞免疫改变相关

2024-02-292
OAAI
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19
2023-12-2211
OA
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia
2023-08-311
OAAI
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID

SARS-CoV-2 mRNA疫苗接种后免疫功能低下个体免疫原性的真实世界评估: 前瞻性临床试验COVAXID的一年随访

2023-08-016
OAAI
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
2023-07-1215
OAAI
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8+ T cells towards the center of human lung tumors

组织固有的自然杀伤细胞,先天淋巴样细胞和CD8 T细胞向人类肺肿瘤中心的积累

2023-07-1110
OA
Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide
2023-07-016
OAAI
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age
2023-03-1415
OAAI